Renault-Nissan's workers at its car plant in Tamil Nadu, southern India will go on strike today for the failure of the company to meet their COVID-related safety demands.
The strike threat comes ahead of a court hearing over workers' allegations that social distancing norms were being flouted and factory health policies did not sufficiently address the risk to lives.
The union, which represents around 3,500 workers at the plant, added they would not return until they felt safe.
Nissan, which owns a majority stake in the plant, declined to comment, saying the matter was in court.
Renault-Nissan rejected workers' allegations before an Indian court last week, adding it needed to continue production to meet orders.
Tamil Nadu, an auto hub known as India's Detroit, has over 30,000 COVID-19 cases a day.
The state is under a lockdown until May 31 but some factories, including auto plants, continue to operate.


Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs
Gold Prices Surge to Record Highs as Geopolitical Tensions Fuel Safe-Haven Demand
Oil Prices Ease in Asia as Geopolitical Risks Clash With Weak Demand Outlook
Italy Fines Apple €98.6 Million Over App Store Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Yen Stabilizes Near Lows as Japan Signals Readiness to Intervene Amid Dollar Weakness
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Why U.S. Coffee Prices Are Staying High Despite Trump’s Tariff Rollbacks
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



